Japan, Aug. 6 -- ALAMAB THERAPEUTICS INC has got intellectual property rights for 'CONNEXIN 43 ANTIBODIES AND USE THEREOF.' Other related details are as follows:

Application Number: JP,2025-036066

Category (FI): A61P17/14,C12N15/13,C12N5/12,C12N5/10,A61P29/00,101,A61P25/24,A61P25/18,C12N15/06,100,C12N15/86@Z,C12N15/63@Z,C07K16/28,A61K39/395@N,A61K39/395@D,A61P29/00,A61P25/28,C12N1/15,A61P43/00,105,A61P25/00,A61P19/02,A61P37/00,A61P11/06,A61P13/12,A61P1/16,A61P25/30,A61P25/14,A61P25/16,C12N1/19,C12N1/21,A61P3/10,A61P21/04,A61P17/00,A61P5/14,A61P11/00,A61P1/04,A61P9/10,A61P37/06,A61P7/06,A61P7/04,A61P15/00,A61P5/18,A61P27/02,A61P3/00

Stage: Grant (IP right granted following substantive examination.)

Filing Date: March 7, 2025

Publication...